Successful Treatment of Symptomatic Coronary Endothelial Dysfunction With Enhanced External Counterpulsation

Bonetti, Piero O.; Gadasalli, Suresh N.; Lerman, Amir; Barsness, Gregory W.
May 2004
Mayo Clinic Proceedings;May2004, Vol. 79 Issue 5, p690
Academic Journal
Enhanced external counterpulsation (EECP) is a valuable therapeutic option for patients with coronary artery disease and refractory angina. Although the exact mechanisms by which this technique exerts favorable effects remain unclear, improvement in endothelial function is con- sidered a potential mechanism contributing to the clinical benefit associated with EECP. We describe a young woman with severely symptomatic coronary endothelial dysfunction in the absence of obstructive coronary artery.


Related Articles

  • Care after Coronary-Artery Bypass Surgery. Charlson, Mary E.; Isom, O. Wayne // New England Journal of Medicine;4/10/2003, Vol. 348 Issue 15, p1456 

    Reports the case of a 71-year-old woman who underwent coronary-artery bypass surgery six months before a visit to her primary care physician. Medical history which included myocardial infarction five years previous to her current symptoms of depression and lack of concentration; Intraoperative...

  • Spontaneous Closure of Post-Myocardial Infarction Ventricular Septal Rupture. Mittal, Chander Mohan; Aslam, Naved; Mohan, Bishav; Tandon, Rohit; Sood, Naresh; Wander, Gurpreet Singh // Texas Heart Institute Journal;2011, Vol. 38 Issue 5, p596 

    The article discusses the case of a 55-year-old man with hypertension who was diagnosed with acute anterolateral-wall myocardial infarction. His symptoms included severe, acute-onset chest pain, vomiting and diaphoresis. An apical pansystolic murmur was detected during examination, while an...

  • How Safe Is the Combination of Aspirin and ACE Inhibitors? Miller, Karl E. // American Family Physician;1/1/2000, Vol. 61 Issue 1, p222 

    Discusses the study `Aspirin and Mortality in Patients Treated With Angiotensin-Converting Enzyme Inhibitors. A Cohort of 11,575 Patients With Coronary Artery Disease,' by J. Leor and colleagues published in the June 1999 issue of the `Journal of American College Cardiology.'

  • Combination Therapy with Angiotensin Converting Enzyme Inhibition and AT1 Receptor Inhibitor on Ventricular Remodeling After Myocardial Infarction in Rats. Zornoff, Leonardo A. M.; Paiva, S�rgio A. R.; Matsubara, Beatriz B.; Matsubara, Luiz B.; Spadaro, Joel // Journal of Cardiovascular Pharmacology & Therapeutics;Sep2000, Vol. 5 Issue 3, p203 

    The article discusses the results of a study comparing the combined administration of angiotensin converting enzyme (ACE) inhibitor and angiotensin II type I (AT, 1 ) receptor antagonist against the drugs' individual effects. It is noted that the study was conducted on rats that suffered from...

  • Trandolapril/Verapamil Sustained Release: A Review of its Use in the Treatment of Essential Hypertension. Reynolds, Neil A.; Wagstaff, Antona J.; Keam, Susan J. // Drugs;2005, Vol. 65 Issue 13, p1893 

    Trandolapril/verapamil sustained release (SR) [Tarka®] is an oral, fixed-dose combination of the ACE inhibitor trandolapril and the SR formulation of the phenylalkylamine calcium channel antagonist verapamil. It is indicated for the treatment of hypertension in patients who require more than...

  • The effects of perindopril on QT duration and dispersion in patients with coronary slow flow. Guntekin, Unal; Gumrukcuoglu, Hasan; Gunes, Yilmaz; Gunes, Ahmet; Simsek, Hakki; Sahin, Musa; Sezen, Yusuf; Akdag, Serkan; Tuncer, Mustafa // Heart & Vessels;Jul2011, Vol. 26 Issue 4, p357 

    Coronary slow flow (CSF) is characterized by delayed opacification of coronary arteries in the absence epicardial occlusive disease. QT duration and dispersion have been reported to be longer in patients with CSF. ACE inhibitors may improve CSF through positive effects on endothelial function....

  • Microvascular Coronary Dysfunction in a Woman With Signs and Symptoms of Myocardial Ischemia but No Obstructive Coronary Artery Disease. Kahlon, Ravi S.; Kothawade, Kamlesh; Shufelt, Chrisandra; Kar, Saibal; Mehta, Puja K.; Merz, C. Noel Bairey // Journal of Medical Cases;2013, Vol. 4 Issue 4, p271 

    Women with signs and symptoms of myocardial ischemia often have no obstructive coronary artery disease by invasive coronary angiography when compared to men. Microvascular coronary dysfunction (MCD) is thought to be a key contributory mechanism for myocardial ischemia in women with chest pain...

  • Coronary–pulmonary artery fistula: value of 64-MDCT imaging. Natarajan, A.; Khokhar, A.A.; Kirk, P.; Patel, H.H.; Turner, D. // QJM: An International Journal of Medicine;Jan2013, Vol. 106 Issue 1, p91 

    No abstract available.

  • Outcomes in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome with Elevated Cardiac Troponin but Non-obstructive Coronary Disease on Angiography. Aldous, Sally; Elliott, John; McClean, Dougal; Puri, Aniket; Richards, A. Mark // Heart, Lung & Circulation;Sep2015, Vol. 24 Issue 9, p869 

    Background Many patients provisionally diagnosed with acute myocardial infarction (AMI) have angiographically unobstructed coronary arteries. Despite other potential causes, patients are often diagnosed as AMI with psychosocial implications and medication burden. The aim of this audit was to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics